MedKoo Cat#: 413685 | Name: Dicarbine

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Dicarbine blocks dopamine receptors in various brain parts and prevents the depression of the conditioned defence reflexes caused by stimulation of the mesencephalic portion of the reticular formation. Dicarbine could be used in the schizophrenia and alcoholic psychosis studies.

Chemical Structure

Dicarbine
CAS#17411-19-7

Theoretical Analysis

MedKoo Cat#: 413685

Name: Dicarbine

CAS#: 17411-19-7

Chemical Formula: C13H18N2

Exact Mass: 202.1470

Molecular Weight: 202.30

Elemental Analysis: C, 77.18; H, 8.97; N, 13.85

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Dicarbine; Dicarbina; Dicarbinum
IUPAC/Chemical Name
1H-Pyrido(4,3-b)indole, 2,3,4,4a,5,9b-hexahydro-2,8-dimethyl-
InChi Key
CYJQCYXRNNCURD-UHFFFAOYSA-N
InChi Code
InChI=1S/C13H18N2/c1-9-3-4-12-10(7-9)11-8-15(2)6-5-13(11)14-12/h3-4,7,11,13-14H,5-6,8H2,1-2H3
SMILES Code
CC1=CC2=C(NC3C2CN(C)CC3)C=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 202.30 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Valachová K, Mach M, Šoltés L. Oxidative Degradation of High-Molar-Mass Hyaluronan: Effects of Some Indole Derivatives to Hyaluronan Decay. Int J Mol Sci. 2020 Aug 5;21(16):5609. doi: 10.3390/ijms21165609. PMID: 32764392; PMCID: PMC7460571. 2: Augustyniak A, Bartosz G, Cipak A, Duburs G, Horáková L, Luczaj W, Majekova M, Odysseos AD, Rackova L, Skrzydlewska E, Stefek M, Strosová M, Tirzitis G, Venskutonis PR, Viskupicova J, Vraka PS, Zarković N. Natural and synthetic antioxidants: an updated overview. Free Radic Res. 2010 Oct;44(10):1216-62. doi: 10.3109/10715762.2010.508495. PMID: 20836663. 3: Račková L, Kuniaková M. Acidotropic properties of synthetic hexahydropyridoindole antioxidants. Gen Physiol Biophys. 2015 Oct;34(4):367-82. doi: 10.4149/gpb_2015016. PMID: 26221744. 4: Sreenilayam G, Fasan R. Myoglobin-catalyzed intermolecular carbene N-H insertion with arylamine substrates. Chem Commun (Camb). 2015 Jan 28;51(8):1532-4. doi: 10.1039/c4cc08753d. Erratum in: Chem Commun (Camb). 2015 Jan 31;51(9):1744. PMID: 25504318; PMCID: PMC4282819. 5: Chorvatovicová D, Horváthová E, Slamenová D. Antimutagenic effects of stobadine: review of results. Life Sci. 1999;65(18-19):2015-7. doi: 10.1016/s0024-3205(99)00468-3. PMID: 10576458. 6: Stolc S, Vlkolinský R, Pavlásek J. Neuroprotection by the pyridoindole stobadine: a minireview. Brain Res Bull. 1997;42(5):335-40. doi: 10.1016/s0361-9230(96)00294-8. PMID: 9092873. 7: Bezek S, Soltés L, Scasnár V, Bauerová K, Kállay Z, Durisová M, Mihalová D, Bohov P, Faberová V, Kukan M, Trnovec T, Koprda V. Pharmacokinetic study of stobadine. Life Sci. 1999;65(18-19):2003-5. doi: 10.1016/s0024-3205(99)00465-8. PMID: 10576455. 8: Juranek I, Horakova L, Rackova L, Stefek M. Antioxidants in treating pathologies involving oxidative damage: an update on medicinal chemistry and biological activity of stobadine and related pyridoindoles. Curr Med Chem. 2010;17(6):552-70. doi: 10.2174/092986710790416317. PMID: 20015031. 9: Horáková L, Stolc S. Antioxidant and pharmacodynamic effects of pyridoindole stobadine. Gen Pharmacol. 1998 May;30(5):627-38. doi: 10.1016/s0306-3623(97)00300-5. PMID: 9559311. 10: Kuwata S, Ikariya T. Metal-ligand bifunctional reactivity and catalysis of protic N-heterocyclic carbene and pyrazole complexes featuring β-NH units. Chem Commun (Camb). 2014 Nov 28;50(92):14290-300. doi: 10.1039/c4cc04457f. PMID: 25074357.